
Registration
The registration system is now open
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The ESMO Targeted Anticancer Therapies Virtual Congress 2021, known as “The Home of Phase I in Oncology” will offer participants a glimpse of the future of targeted anticancer therapies.
It is the premier international meeting focusing on promising new anticancer targets and agents, with a particular focus on those in early phase clinical development. Stakeholders from academy and industry will discuss with clinicians, researchers and regulators the global dissemination of knowledge and clinical research expertise in the field of innovative cancer therapeutics, to the benefit of cancer patients worldwide.
ESMO Head Office
Via Ginevra 4
6900 Lugano
Switzerland
meetings@esmo.org
The registration system is now open
The ESMO TAT Virtual Congress 2021 virtual programme is now online!
Abstracts submission is now closed.
Find here instructions to assist you with your presentation.
Find out the TAT 2021 Scientific Commitee Co-Chairs and Members
Find out more information about the sponsors of TAT 2021
Industry partners: find out how to get involved
Information for media representatives
Get in touch with the organisers of TAT 2021.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.